Cargando…

Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer

Although cisplatin is one of the most effective antitumor drugs for ovarian cancer, the emergence of chemoresistance to cisplatin in over 80% of initially responsive patients is a major barrier to successful therapy. The precise mechanisms underlying the development of cisplatin resistance are not f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Ye-Na, Sung, Hye Youn, Yang, San-Duk, Chae, Yun Ju, Ju, Woong, Ahn, Jung-Hyuck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746511/ https://www.ncbi.nlm.nih.gov/pubmed/29302211 http://dx.doi.org/10.4196/kjpp.2018.22.1.43

Ejemplares similares

Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer
por: Sung, Hye Youn, et al.
Publicado: (2017)

Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer
por: Sung, Hye Youn, et al.
Publicado: (2017)

Novel endo-α-N-acetylgalactosaminidases with broader substrate specificity
por: Koutsioulis, Dimitris, et al.
Publicado: (2008)

DNA Hypomethylation-Mediated Overexpression of Carbonic Anhydrase 9 Induces an Aggressive Phenotype in Ovarian Cancer Cells
por: Sung, Hye Youn, et al.
Publicado: (2014)

Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance
por: Sung, Hye Youn, et al.
Publicado: (2023)

Enzymatic Conversion of RBCs by α-N-Acetylgalactosaminidase from Spirosoma linguale
por: Malinski, Thomas J., et al.
Publicado: (2019)

Overexpression of Mucin 13 due to Promoter Methylation Promotes Aggressive Behavior in Ovarian Cancer Cells
por: Sung, Hye Youn, et al.
Publicado: (2014)

Chemical and structural characterization of α-N-acetylgalactosaminidase I and II from starfish, asterina amurensis
por: Rashid, Md. Harun-Or, et al.
Publicado: (2017)

shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines
por: Saburi, Ehsan, et al.
Publicado: (2017)

Schistosoma mansoni α-N-acetylgalactosaminidase (SmNAGAL) regulates coordinated parasite movement and egg production
por: Hulme, Benjamin J., et al.
Publicado: (2022)

Effects of Sponge-Derived Alkaloids on Activities of the Bacterial α-D-Galactosidase and Human Cancer Cell α-N-Acetylgalactosaminidase
por: Utkina, Natalia, et al.
Publicado: (2021)

GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients
por: Thyer, Lynda, et al.
Publicado: (2013)

Characterization of gana-1, a Caenorhabditis elegans gene encoding a single ortholog of vertebrate α-galactosidase and α-N-acetylgalactosaminidase
por: Hujová, Jana, et al.
Publicado: (2005)

The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α-N-Acetylgalactosaminidase of Human Colon Carcinoma Cells
por: Bakunina, Irina, et al.
Publicado: (2018)

Effect of Phlorotannins from Brown Algae Costaria costata on α-N-Acetylgalactosaminidase Produced by Duodenal Adenocarcinoma and Melanoma Cells
por: Bakunina, Irina, et al.
Publicado: (2022)

Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. I. A new assay for lysosomal α-N-acetylgalactosaminidase
por: Albracht, Simon P.J., et al.
Publicado: (2017)

The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
por: Korbelik, M., et al.
Publicado: (1998)

Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region
por: Albracht, Simon P.J., et al.
Publicado: (2017)

Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer
por: Jeon, Mi-Seong, et al.
Publicado: (2016)

Amyloid Beta-Mediated Epigenetic Alteration of Insulin-Like Growth Factor Binding Protein 3 Controls Cell Survival in Alzheimer's Disease
por: Sung, Hye Youn, et al.
Publicado: (2014)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

The Effect of α-Mangostin and Cisplatin on Ovarian Cancer Cells and the Microenvironment
por: Borzdziłowska, Paulina, et al.
Publicado: (2022)

Role and mechanism of FOXG1-related epigenetic modifications in cisplatin-induced hair cell damage
por: Mu, Yu-rong, et al.
Publicado: (2023)

Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells
por: Zhao, Lingqin, et al.
Publicado: (2019)

Protective role of ABCA1 in ischemic preconditioning is mediated by downregulation of miR-33-5p and miR-135-5p
por: Sung, Hye Youn, et al.
Publicado: (2021)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers
por: Sarwar, Sadia, et al.
Publicado: (2021)

Methylation and demethylation of DNA and histones in chromatin: the most complicated epigenetic marker
por: Youn, Hong-Duk
Publicado: (2017)

Cisplatin Resistance: Genetic and Epigenetic Factors Involved
por: Lugones, Yuliannis, et al.
Publicado: (2022)

Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice
por: Lochmann, Timothy L., et al.
Publicado: (2015)

Loss of Rb1 by epigenetic modification regulates expansion of MDSC in cancer
por: Youn, Je-In, et al.
Publicado: (2014)

Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
por: Yu, Wei, et al.
Publicado: (2011)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Epigenetic modifications in rheumatoid arthritis
por: Strietholt, Simon, et al.
Publicado: (2008)

Epigenetic Modifications as Therapeutic Targets
por: Kelly, Theresa K, et al.
Publicado: (2010)

Epigenetic modifications in cardiovascular disease
por: Lorenzen, Johan M., et al.
Publicado: (2012)

Epigenetic Modifications and Diabetic Retinopathy
por: Kowluru, Renu A., et al.
Publicado: (2013)

Epigenetic Modifications in Essential Hypertension
por: Wise, Ingrid A., et al.
Publicado: (2016)

Epigenetic modifications and diabetic nephropathy
por: Reddy, Marpadga A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4fdj2qjmf6i71ef1uq78aacvg7